is an infectious respiratory disease caused by SARS-CoV-2, previously
referred to as "2019 novel coronavirus."1
use of a SARS-CoV-2 vaccine in patients treated with dulaglutide has
not been studied by Lilly.
regarding the use of any vaccination, including SARS-CoV-2 vaccines,
in patients treated with dulaglutide should be made at the discretion
of the prescribing physician using their best clinical judgment, and
must be made by the clinician after careful consideration of risk
factors of the patient as well as the risks and benefits of
vaccination. Consultation with an infectious disease expert may be
helpful in high-risk or emergency situations such as the current
impact of vaccination on blood glucose concentration
International Diabetes Federation IDF states that after any
vaccination the blood glucose levels might rise for a few days.2
resources on COVID-19 Vaccines and Diabetes
information on COVID-19 vaccines and diabetes, please refer to
current information on COVID-19 and COVID-19 vaccines in gereral,
please refer to
Naming the coronavirus disease (COVID-19) and the virus that causes
it. World Health Organization. Accessed March 17, 2020.
International Diabetes Federation Europe. Diabetes & Coronavirus
Accessed April 29, 2021
Coronavirus disease (COVID-19) outbreak. European web page of the
World Health Organization. Accessed March 20, 2020.
COVID-19. European Centre for Disease Prevention and Control.
Accessed March 20, 2020.
= coronavirus disease 2019
= European Centre for Disease Prevention and Control
WHO = World Health Organization (European regional office)
= International Diabetes Federation
= Eli Lilly and Company
= severe acute respiratory syndrome coronavirus 2